What Does MIMETAS Do?

Total employees92
HeadquartersLeiden
Founded2013

MIMETAS is at the forefront of organ-on-a-chip technology, dedicated to revolutionizing drug discovery and development. The company develops and commercializes the OrganoPlate®, a microfluidic platform that enables the creation of predictive 3D human tissue and disease models. These models are used by pharmaceutical companies, biotech firms, and academic institutions globally to improve the efficiency and translatability of preclinical research, ultimately aiming to bring better and safer medicines to patients faster. MIMETAS also offers contract research services and develops ready-to-use assay products.

Where Is MIMETAS's Headquarters?

HQ Function

Serves as the global headquarters, housing primary research and development labs, OrganoPlate® manufacturing facilities, global sales operations, and corporate administration.

Notable Features:

Located within the Leiden Bio Science Park, known for its state-of-the-art laboratory facilities and a vibrant ecosystem of biotech companies and research institutions. The facility itself is likely equipped with advanced microfabrication and cell culture laboratories.

Work Culture:

Fosters an innovative, collaborative, and scientifically-driven environment. Employees are passionate about advancing human health through cutting-edge technology and rigorous research. There's a strong emphasis on teamwork, agility, and pioneering solutions in the organ-on-a-chip field.

HQ Significance:

The Leiden headquarters is the birthplace and central nervous system of MIMETAS's pioneering work in organ-on-a-chip technology, driving product innovation, global strategy, and manufacturing of their core OrganoPlate® platform.

Values Reflected in HQ: The headquarters reflects MIMETAS's core values of innovation, scientific excellence, quality, and a collaborative spirit, evident in its state-of-the-art labs and its location within a leading life sciences hub.

Location:

MIMETAS supports drug discovery and development globally through its innovative OrganoPlate® platform and associated products and services. Key functions supported globally include sales and distribution of OrganoPlates® and assay kits, contract research services utilizing their 3D tissue models, technical support for customers, and scientific collaborations with leading pharmaceutical companies, biotech firms, and academic institutions across Europe, North America, and Asia-Pacific.

Street Address:

J.H. Oortweg 19

City:

Leiden

State/Province:

Zuid-Holland

Country:

The Netherlands

Where Else Does MIMETAS Operate Around the World?

Rockville, Maryland, USA

Address: 9600 Gudelsky Drive, Rockville, MD 20850, USA

To provide localized support and expand MIMETAS's footprint in the significant U.S. life sciences sector, facilitating closer engagement with key customers and partners.

Tokyo, Japan

Address: Shinkawa KS Bldg 4F, 1-3-2 Shinkawa, Chuo-ku, Tokyo 104-0033, Japan

To cater to the growing demand for organ-on-a-chip technology in Asia, enabling direct customer interaction, support, and market penetration in this key pharmaceutical and research hub.

Buying Intent Signals for MIMETAS

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading MIMETAS? Meet the Executive Team

As of April 2025, MIMETAS' leadership includes:

Jos Joore - Chief Executive Officer
Paul Vulto - Managing Director
Bas Trietsch - Chief Technology Officer
Remko van Vught - Chief Business Officer
Nienke Weijmar - Chief Financial Officer
Kristin Eales - Chief Scientific Officer

Who's Investing in MIMETAS?

MIMETAS has been backed by several prominent investors over the years, including:

Korys
Oost NL
Zeeuws Investerings Fonds (ZIF)
Aglaia Oncology Fund II
InnovationQuarter
Cathay Health
sgreen
European Investment Bank (EIB - debt financing)

What Leadership Changes Has MIMETAS Seen Recently?

Hire0
Exits0

Within the last 12 months (approx. May 2023 - May 2024), no major publicly announced executive hires or departures have been prominently featured for MIMETAS. The existing leadership team, which saw key appointments like Kristin Eales as CSO (January 2023) and Nienke Weijmar as CFO (November 2022) prior to this period, appears to be stable and guiding the company's growth.

What Technology (Tech Stack) Is Used byMIMETAS?

Discover the tools MIMETAS uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

MIMETAS Email Formats and Examples

MIMETAS likely utilizes common professional email formats for its employees. Based on industry patterns and available data, primary formats include [first].[last]@mimetas.com or [first_initial][last]@mimetas.com.

[first].[last]@mimetas.com (e.g., j.joore@mimetas.com) or [first_initial][last]@mimetas.com (e.g., jjoore@mimetas.com)

Format

j.joore@mimetas.com

Example

85%

Success rate

What's the Latest News About MIMETAS?

mimetas.comJuly 19, 2023

MIMETAS and AstraZeneca Extend Collaboration to Develop Novel Kidney Disease Models on the OrganoPlate® Platform

MIMETAS announced an extension of its collaboration with AstraZeneca to develop novel human immunocompetent kidney-on-a-chip models. The models will be used to investigate drug-induced kidney injury and to explore new therapeutic avenues for kidney diseases....more

mimetas.comJune 20, 2023

MIMETAS Launches Assay Ready Kidney Proximal Tubules in OrganoPlate®

MIMETAS introduced its new Assay Ready product, Kidney Proximal Tubules in OrganoPlate®. This product provides researchers with ready-to-use 3D kidney models, simplifying adoption and accelerating research in nephrotoxicity and kidney disease....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including MIMETAS, are just a search away.